Why it's important to test drugs on pregnant women

May 4, 2018 by Mackenzie Graham, The Conversation
The potential risks to the unborn child should be minimal. Credit: GagliardiImages/Shutterstock.com

Vulnerable groups, such as children, prisoners and people with limited mental capacity, are usually excluded from drug trials. And, until quite recently, it was considered unethical to test drugs on pregnant women, too (the thalidomide scandal is probably not too far from people's minds). But the tide is turning. The U.S. Food and Drug Administration (FDA) recently published a draft guidance for how and when to include pregnant women in drug trials.

According to Drug and Therapeutic Bulletin, about one in ten have a that requires medication. And at least four in ten take some form of medication during their pregnancy. Yet there is no -safety information for these women to rely on. Many women probably forgo their meds for precisely this reason. But, as the FDA guidance points out, this could result in more harm to the woman and the unborn child than if she had taken the drugs.

Pregnant women are entitled to high-quality, evidence-based healthcare as much as the rest of the population. The benefits and burdens of research must be distributed fairly. Pregnant women should no longer be considered a vulnerable group – at least, not in the context of drug testing.

There is nothing specific about pregnancy that makes a woman unable to provide informed consent or renders her susceptible to influence or coercion. Of course, there are to mother and baby in taking part in this kind of research, and these risks must taken seriously, but they are not reason enough for excluding pregnant women from participating.

Ethical guidelines, prepared by the Council for InternationalOrganisations of Medical Sciences and the World Health Organisation, state that if research has no prospect of direct benefit to the pregnant woman, the risks to the foetus must be minimal (minimal risk being generally understood as the risks involved in everyday life). When research is likely to have a direct clinical benefit for pregnant woman, an increase over minimal risk may be permitted.

These guidelines can be difficult to interpret. For example, the concept of "minimal risk" is vague and may depend on context. It is also unclear how much risk to a foetus is acceptable if there is a prospect of direct benefit to the pregnant woman.

Suppose a treatment only available through research could save a pregnant woman's life, but placed her foetus at a significant risk of being born with severe disabilities. Here, the potential benefits to the pregnant woman must be weighed against the potential risks to the future child. It is very often unclear how this balance should be struck.

We can't just avoid the issue

Fortunately, a great deal of potential clinical research involving pregnant women does not require such a careful balancing of risks and benefits. Millions of pregnant women are already using various drugs. They could easily form a research population, investigating dosing and pregnancy outcome. Such studies would involve little or no additional risk to the foetus or the .

Simply avoiding the issue is not a viable solution. Guidelines, like those issued by the FDA, are useful and are needed to increase consistency in the regulation. Further funding for research, investigating drugs in pregnant women and for pregnant women, is needed.

Ethicists must continue to work to develop frameworks for managing the risk-benefit trade offs between woman and . Failure to do so will continue to deprive pregnant women of a fair distribution of the benefits of .

Explore further: Zika vaccine research—guidance for including pregnant women

Related Stories

Zika vaccine research—guidance for including pregnant women

June 30, 2017
New guidance for including pregnant woman and their babies in Zika vaccine research has been published today. It has been issued by a group of international experts in vaccinology, maternal and child health, public health ...

Can medication for anxiety and sleeping problems during pregnancy harm the child?

August 14, 2017
Many women experience anxiety and sleeping problems during pregnancy. The research so far has been unable to determine the safety for the child if the mother is prescribed drugs to treat these disorders.

Many pregnant women search the Internet for medication safety information

September 7, 2017
A new study reveals that due to a lack of specific recommendations for medication use during pregnancy, many pregnant women search the Internet for information.

Ethics of routine treatment to pregnant women questioned

March 28, 2014
Routine treatment given to pregnant women who have a RhD negative blood group is being questioned on ethical grounds in a recent report published in Biomedical Central.

Mother-child HIV transmission at all time low in U.K. and Ireland

December 8, 2016
The number of mothers passing the HIV virus to their babies has fallen to a new record low in the UK and Ireland thanks to the very high take-up of antenatal HIV screening and treatment which reduces virus levels in the pregnant ...

Diet linked to asthma severity in pregnancy

May 21, 2015
A University of Adelaide study has found asthmatic women who eat a high-fat, high-sugar diet are more likely to have uncontrolled asthma while pregnant.

Recommended for you

Why mothers in mainland China, Hong Kong and Taiwan choose cesarean delivery

October 16, 2018
Pregnant women in mainland China, Hong Kong, and Taiwan are more likely to express preference for cesarean section (CS) as their mode of delivery later in pregnancy and postpartum, as compared to early in pregnancy, according ...

Importance of cell cycle and cellular senescence in the placenta discovered

October 15, 2018
Working with researchers from Stanford University and St. Anna Children's Cancer Research, researchers from Jürgen Pollheimer's laboratory at the Medical University of Vienna's Department of Obstetrics and Gynecology have ...

C-section rates have nearly doubled since 2000: study

October 12, 2018
(HealthDay)—The number of women delivering babies via cesarean section has nearly doubled worldwide since 2000, to about 21 percent, new research shows.

Study of nearly 41,000 women who almost died giving birth shows who's most at risk

October 10, 2018
Tens of thousands of American women each year need emergency treatment to save their lives while they deliver their babies, or immediately after. A new study shows how much their risk of a life-threatening birth depends on ...

In childbirth, when to begin pushing does not affect C-section rates

October 9, 2018
More than 3 million women in the United States give birth each year. But obstetricians have differing opinions about when women should begin pushing during labor and whether the timing of pushing increases the likelihood ...

Why single embryo transfer during IVF sometimes results in twins or triplets

October 8, 2018
It has been known for some time that it is better to transfer a single embryo to a woman's womb during assisted reproduction treatment (ART) rather than several embryos in order to avoid a multiple pregnancy and the risks ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.